S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The “Perfect Storm” for Gold (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial

TScan Therapeutics (TCRX) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free TCRX Stock Alerts
$6.92
+0.17 (+2.52%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoTScan Therapeutics (NASDAQ:TCRX) Rating Reiterated by Wedbush
americanbankingnews.com - April 19 at 1:58 AM
marketbeat.com logoWedbush Comments on TScan Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:TCRX)
marketbeat.com - April 18 at 6:31 AM
investing.com logoTScan launches $125 million public stock offering
investing.com - April 18 at 12:57 AM
marketbeat.com logoTScan Therapeutics (NASDAQ:TCRX) Stock Rating Reaffirmed by Wedbush
marketbeat.com - April 17 at 3:51 PM
finanznachrichten.de logoTScan Therapeutics, Inc.: TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
finanznachrichten.de - April 17 at 9:55 AM
markets.businessinsider.com logoTScan Therapeutics Announces Pricing Of Public Offering - Quick Facts
markets.businessinsider.com - April 17 at 9:55 AM
finance.yahoo.com logoTScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
finance.yahoo.com - April 17 at 9:55 AM
finance.yahoo.com logoTScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
finance.yahoo.com - April 16 at 7:19 PM
globenewswire.com logoTScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
globenewswire.com - April 16 at 4:01 PM
markets.businessinsider.com logoTScan Therapeutics Appoints Chrystal Louis As Chief Medical Officer - Quick Facts
markets.businessinsider.com - April 8 at 8:42 AM
markets.businessinsider.com logoTScan Therapeutics Appoints Louis As CMO
markets.businessinsider.com - April 8 at 8:42 AM
finance.yahoo.com logoTScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
finance.yahoo.com - April 8 at 8:42 AM
globenewswire.com logoTScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D.
globenewswire.com - April 8 at 8:00 AM
globenewswire.com logoTScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 2 at 7:00 AM
finance.yahoo.com logoHedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%
finance.yahoo.com - March 26 at 11:06 PM
investorplace.com logoLow-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
investorplace.com - March 17 at 2:58 PM
marketbeat.com logoTScan Therapeutics, Inc. (NASDAQ:TCRX) Sees Significant Decrease in Short Interest
marketbeat.com - March 14 at 3:15 PM
markets.businessinsider.com logoPositive Outlook for TScan Therapeutics with Promising Clinical Trials and Strong Financial Position
markets.businessinsider.com - March 11 at 1:18 AM
marketbeat.com logoHC Wainwright Comments on TScan Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:TCRX)
marketbeat.com - March 8 at 7:22 AM
markets.businessinsider.com logoStrong Buy Rating for TScan Therapeutics Amidst Promising Drug Developments and Financial Health
markets.businessinsider.com - March 7 at 6:17 PM
markets.businessinsider.com logoBuy Rating Affirmed for TScan Therapeutics Following Promising Phase 1 Results
markets.businessinsider.com - March 7 at 6:17 PM
finance.yahoo.com logoTScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline
finance.yahoo.com - March 7 at 6:17 PM
marketbeat.com logoTScan Therapeutics (NASDAQ:TCRX) Releases Earnings Results
marketbeat.com - March 7 at 10:11 AM
marketbeat.com logoHC Wainwright Reaffirms Buy Rating for TScan Therapeutics (NASDAQ:TCRX)
marketbeat.com - March 7 at 8:20 AM
benzinga.com logoTScan Therapeutics: Q4 Earnings Insights
benzinga.com - March 6 at 5:14 PM
investorplace.com logoTCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 6 at 3:01 PM
marketbeat.com logoTScan Therapeutics' (TCRX) "Outperform" Rating Reaffirmed at Wedbush
marketbeat.com - March 6 at 11:55 AM
globenewswire.com logoTScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
globenewswire.com - March 6 at 7:00 AM
globenewswire.com logoTScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 28 at 7:00 AM
markets.businessinsider.com logoStrong Buy Rating for TScan Therapeutics Backed by Positive Phase 1 Trial Data and Promising Treatment Efficacy
markets.businessinsider.com - February 27 at 11:17 PM
markets.businessinsider.com logoBuy Rating Affirmed for TScan Therapeutics Following Promising TCR-T Therapy Trial Outcomes
markets.businessinsider.com - February 27 at 11:17 PM
globenewswire.com logoTScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
globenewswire.com - February 26 at 7:00 AM
markets.businessinsider.com logoBuy Rating for TScan Therapeutics Supported by Iovance’s FDA Approval and Promising TIL Therapy Benchmark
markets.businessinsider.com - February 21 at 4:22 PM
finance.yahoo.com logoTScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?
finance.yahoo.com - February 19 at 8:55 AM
baystreet.ca logoGlobal Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates
baystreet.ca - February 14 at 11:15 PM
finance.yahoo.com logoTScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
finance.yahoo.com - February 14 at 8:13 AM
globenewswire.com logoTScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
globenewswire.com - February 14 at 7:00 AM
finance.yahoo.com logoTScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
finance.yahoo.com - February 6 at 10:32 AM
msn.com logoTScan Therapeutics Welcomes Jason Amello as New CFO
msn.com - January 30 at 4:51 PM
markets.businessinsider.com logoTScan Appoints Jason Amello As CFO
markets.businessinsider.com - January 29 at 9:00 AM
msn.com logoTScan Therapeutics appoints CFO
msn.com - January 29 at 9:00 AM
finance.yahoo.com logoTScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
finance.yahoo.com - January 29 at 9:00 AM
marketbeat.com logoTScan Therapeutics, Inc. (NASDAQ:TCRX) Short Interest Down 14.6% in January
marketbeat.com - January 28 at 7:35 PM
finance.yahoo.com logoTScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR
finance.yahoo.com - January 18 at 7:25 AM
markets.businessinsider.com logoStrong Buy Rating for TScan Therapeutics Amid Progressive Clinical Advancements
markets.businessinsider.com - January 5 at 8:11 PM
seekingalpha.com logoTScan: Two 2024 TCR-T Data Readouts Could Bring Significant Value
seekingalpha.com - December 27 at 8:23 PM
finance.yahoo.com logoTimothy Barberich Bought 41% More Shares In TScan Therapeutics
finance.yahoo.com - December 23 at 7:51 AM
marketbeat.com logoTimothy J. Barberich Purchases 28,830 Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX) Stock
marketbeat.com - December 21 at 6:48 PM
marketbeat.com logoInsider Buying: TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Acquires 5,000 Shares of Stock
marketbeat.com - December 18 at 7:23 PM
finance.yahoo.com logoTScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
finance.yahoo.com - December 9 at 1:02 PM
Get TScan Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRX and its competitors with MarketBeat's FREE daily newsletter.

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

TCRX Media Mentions By Week

TCRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TCRX
News Sentiment
▼
0.23

0.53
▲
Average
Medical
News Sentiment

TCRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TCRX Articles
This Week
▼
11

2
▲
TCRX Articles
Average Week

Get TScan Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TCRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
How Biden has already won 2024
Porter & Company
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
A.I. Pioneer Issues Urgent Warning to Americans
TradeSmith
BUY ALERT: Billionaires piling into this asset class
Reagan Gold Group